SCHEMBL23319082

SCHEMBL23319082

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccccc4)c(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)c3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.47
▸ ATM Q13315 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ KMT2A Q03164 5/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ RXRA P19793 1/20 0.36
▸ ACP1 P24666 2/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ IL1R1 P14778 1/20 0.35
▸ NTSR1 P30989 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663570 1.00 L3MBTL1 (0.47) L3MBTL1ATMKDM4EKMT2AMEN1
SCHEMBL24780976 0.93 L3MBTL1 (0.40) L3MBTL1ATMKDM4EKMT2AMEN1
SCHEMBL23319009 0.93 L3MBTL1 (0.40) L3MBTL1ATMKDM4EKMT2AMEN1
SCHEMBL23318984 0.93 L3MBTL1 (0.42) L3MBTL1ATMKDM4EKMT2AMEN1
SCHEMBL24780485 0.93 L3MBTL1 (0.42) L3MBTL1ATMKDM4EKMT2AMEN1
SCHEMBL22664000 0.93 L3MBTL1 (0.52) L3MBTL1ATMKDM4EKMT2AMEN1
SCHEMBL23154441 0.93 L3MBTL1 (0.52) L3MBTL1ATMKDM4EKMT2AMEN1
SCHEMBL16943250 0.92 L3MBTL1 (0.46) L3MBTL1ATMKDM4EKMT2AMEN1
SCHEMBL16943248 0.92 L3MBTL1 (0.46) L3MBTL1ATMKDM4EKMT2AMEN1
SCHEMBL16943291 0.92 L3MBTL1 (0.46) L3MBTL1ATMKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220407012-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE SOULBRAIN CO., LTD. (KR) 2022-12-22 — — US disclosed
WO-2021086143-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT-EMITTING DIODE 솔브레인 주식회사 2021-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220407012-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE OCIAD1, AOX1, OXER1 L3MBTL1 113/4885ATM 3796/4885KDM4E 2915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback